Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approvals for Azithromycin Tablets USP, 250 mg and 500 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. Alembic Pharma gets USFDA nod for infection treatment drug
Drug firm Alembic Pharmaceuticals on Tuesday said it has received a final nod from the US health regulator for Azithromycin tablets, used for the tr ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Azithromycin Tablets USP, 600 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. Earnings Call Transcript - Q3FY20 for Alembic Pharma
Transcript of Conference Call between Management and Analysts for Q3FY20
Alembic Pharma reports better numbers in Q3; here are highlights of analyst call
The company reported 33.8 percent jump in its Q3FY20 net profit to Rs 227.31 crore, EBITDA up 32.4 percent at Rs 325.46 crore Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Bosentan Tablets, 62.5 mg and 125 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. Alembic Pharma gets final USFDA nod for Fenofibrate tablets
"Alembic Pharmaceuticals Limited (Alembic)...has received final approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Bimatoprost Ophthalmic Solution, 0.03%. Please find enclosed herewith our press release. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fenofibrate Tablets USP, 54 mg and 160 mg. Please find enclosed herewith our press release.
